- Home
- GOSS vs PRPL Comparison
GOSS vs PRPL Comparison
Compare GOSS & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | PRPL |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.6M | 76.9M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GOSS | PRPL |
|---|---|---|
| Price | $0.35 | $0.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $4.19 | $0.65 |
| AVG Volume (30 Days) | ★ 4.5M | 480.1K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 152.75 |
| EPS | N/A | ★ N/A |
| Revenue | $48,471,000.00 | ★ $468,725,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | $201.64 | $6.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.31 | $0.44 |
| 52 Week High | $3.87 | $1.26 |
Technical Indicators
Market Signals| Indicator | GOSS | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 40.16 | 30.02 |
| Support Level | $0.33 | N/A |
| Resistance Level | $0.47 | $0.72 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 60.49 | 5.76 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.